Gene: PPP1R35
Official Full Name: protein phosphatase 1 regulatory subunit 35provided by HGNC
Gene Summary: Predicted to enable phosphatase binding activity and protein phosphatase inhibitor activity. Involved in positive regulation of centriole elongation. Located in centriole and centrosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27331 | PPP1R35 Knockout cell line (HeLa) | Human | PPP1R35 | 1:3~1:6 | Negative | Online Inquiry |
KO27332 | PPP1R35 Knockout cell line (HCT 116) | Human | PPP1R35 | 1:2~1:4 | Negative | Online Inquiry |
KO27333 | PPP1R35 Knockout cell line (HEK293) | Human | PPP1R35 | 1:3~1:6 | Negative | Online Inquiry |
KO27334 | PPP1R35 Knockout cell line (A549) | Human | PPP1R35 | 1:3~1:4 | Negative | Online Inquiry |
PPP1R35 Gene Knockout Cell Lines are specialized cellular models in which the PPP1R35 gene has been systematically inactivated through targeted gene editing techniques such as CRISPR/Cas9. This loss-of-function model serves to unravel the specific role of the PPP1R35 protein, which is implicated in various cellular signaling pathways and processes, including cell division and apoptosis. By disrupting the expression of this gene, researchers can study the resultant phenotypic changes, thereby elucidating the gene's contributions to normal cellular function and its potential involvement in disease mechanisms.
The primary mechanism of action for these cell lines includes the complete knockout of PPP1R35, leading to a cascade of biological effects that facilitate research into both basic and translational science. These cell lines can be utilized in a multitude of studies, including but not limited to gene function studies, drug response assays, and analysis of cellular processes under pathological conditions, such as cancer or metabolic disorders.
The scientific importance of PPP1R35 Gene Knockout Cell Lines is underscored by their applications in both research and clinical settings, where they support the development of therapeutics and investigative approaches that target specific molecular pathways. Their ability to provide insights into gene function and regulation establishes them as valuable tools for the research community, particularly in oncology and regenerative medicine.
The specific advantages of our PPP1R35 Gene Knockout Cell Lines include superior stability and reliability compared to similar products on the market. These lines undergo rigorous validation to ensure consistent performance in experimental protocols, making them ideal for longitudinal studies and high-throughput screening assays. Additionally, our expert technical support and resources empower researchers to optimize their experimental designs, thereby enhancing the overall quality and reproducibility of their work.
In conclusion, the PPP1R35 Gene Knockout Cell Lines stand out as a pivotal resource for researchers and clinicians striving to dissect the complexities of cellular biology. Our company prides itself on providing high-quality biological products and unparalleled expertise in genetic engineering, ensuring that you have access to innovative solutions that advance your scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.